Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,609.00
Bid: 1,609.00
Ask: 1,610.00
Change: 5.00 (0.31%)
Spread: 1.00 (0.062%)
Open: 1,602.00
High: 1,610.00
Low: 1,602.00
Prev. Close: 1,604.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Smiths Group - Capital Markets Day 2022

10 Nov 2022 07:00

RNS Number : 9050F
Smiths Group PLC
10 November 2022
 

News Release

10 November 2022

 

 

SMITHS GROUP PLC - CAPITAL MARKETS EVENT

Pioneers of progress - improving our world through smarter engineering

 

Progress on our growth strategy highlighting Flex-Tek, Smiths Interconnect and Sustainability at Smiths

 

Smiths Group plc ("Smiths" or "the Group") announces that it will host a capital markets event today at the Tate Modern in London, with an in-person Q&A session and interactive product exhibition. Presentations are now available to view online and the Q&A will be streamed live at 16.00 GMT on the Smiths website at www.smiths.com/capital-markets-event-2022.

 

Following last year's event, which outlined how the Group will accelerate growth and strengthen execution through the Smiths Value Engine, this year's event will be focused on how the Group is progressing on this strategy with a particular focus on Flex-Tek and Smiths Interconnect and how Sustainability has a pivotal role in accelerating growth.

 

The capital markets event will be led by Smiths Group CEO, Paul Keel and will feature presentations from the Presidents of Flex-Tek, Pat McCaffrey and Smiths Interconnect, Julian Fagge, as well as the Group's Chief Sustainability Officer, John Ostergren, and Group CFO, Clare Scherrer.

 

The Group published its first quarter trading update (available here) covering the three months to the end of October 2022 on 9 November 2022 demonstrating further progress on the strategy, posting organic revenue growth of 13.2%, and reiterating its full year guidance of 4.0-4.5% organic revenue growth for the year with moderate margin improvement. No material update on trading will be provided during the event.

 

Paul Keel, Group Chief Executive, commented:

"Our global team has accomplished a great deal since outlining our strategy last fall and we will give more detail on that accelerating progress today as well as our path to delivering on our medium-term targets.

 

Following a strong FY22, and a strong start to FY23 with six consecutive quarters of growth, we're building a credible track-record. We're grounded in our purpose, powered by our strengths and focused on our three main priorities of Growth, Execution and People. Together this will help us create long term sustainable value for all our stakeholders."

 

Investor enquiries

Media enquiries

 

Jemma Spalton, Smiths Group+44 (0)7867 390 350jemma.spalton@smiths.com

 

Tom Steiner, Smiths Group

+44 (0)7787 415 891

tom.steiner@smiths.com

 

Stephanie Heathers, Smiths Group

+44 (0)7584 113 633

stephanie.heathers@smiths.com

 

Alex Le May, FTI Consulting+44 (0)7702 443 312smiths@fticonsulting.com

 

Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11

About Smiths Group

For over 170 years, Smiths Group has been pioneering progress by improving the world through smarter engineering. We serve millions of people every year, to help create a safer, more efficient and better-connected world, across four major global markets: Energy, General Industry, Safety & Security and Aerospace. Listed on the London Stock Exchange, Smiths employs over 14,700 colleagues in over 50 countries. For more information visit www.smiths.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKLFBLFLXFBZ
Date   Source Headline
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20244:45 pmRNSDirector/PDMR Shareholding
1st May 20243:30 pmRNSTotal Voting Rights
1st May 202410:00 amRNSBlock listing Interim Review
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20249:00 amRNSDirector/PDMR Shareholding
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20244:30 pmRNSTotal Voting Rights
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:15 amRNSShare buyback programme
26th Mar 20247:01 amRNSSmiths Group half year results
26th Mar 20247:00 amRNSDirectorate Change
1st Mar 20247:00 amRNSSmiths sells 830,000 shares in ICU Medical Inc
29th Feb 20249:00 amRNSDirectors' Change in Responsibilities
1st Feb 202410:15 amRNSDirector/PDMR Shareholding
24th Jan 20247:00 amRNSDirectors' Change in Responsibilities
30th Nov 20237:00 amRNSSmiths Group plc - John Crane deep dive
16th Nov 20231:10 pmRNSResult of AGM
16th Nov 20237:00 amRNSSmiths Group plc - Q1 Trading Update
2nd Nov 20232:45 pmRNSDirector/PDMR Shareholding
1st Nov 202310:00 amRNSBlock listing Interim Review
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:25 pmRNSDirector/PDMR Shareholding
12th Oct 202312:35 pmRNSAnnual Financial Report and AGM 2023
4th Oct 202310:00 amRNSDirector/PDMR Shareholding
2nd Oct 202312:10 pmRNSTotal Voting Rights
28th Sep 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSSmiths Group FY23 Full Year Results
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.